AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Cash & Equivalents Over TimeStrong
Percentile Rank67
3Y CAGR-9.9%
5Y CAGR+37.4%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-9.9%/yr
Annual compound
5Y CAGR
+37.4%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
4.9x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $19.94M | -6.6% |
| 2024 | $21.35M | +36.5% |
| 2023 | $15.65M | -42.5% |
| 2022 | $27.22M | +125.0% |
| 2021 | $12.10M | +197.2% |
| 2020 | $4.07M | -27.3% |
| 2019 | $5.60M | - |